Details for New Drug Application (NDA): 065022
✉ Email this page to a colleague
The generic ingredient in BACITRACIN ZINC AND POLYMYXIN B SULFATE is bacitracin zinc; polymyxin b sulfate. There are twenty-seven drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the bacitracin zinc; polymyxin b sulfate profile page.
Summary for 065022
Tradename: | BACITRACIN ZINC AND POLYMYXIN B SULFATE |
Applicant: | Padagis Us |
Ingredient: | bacitracin zinc; polymyxin b sulfate |
Patents: | 0 |
Pharmacology for NDA: 065022
Physiological Effect | Decreased Cell Wall Synthesis & Repair |
Suppliers and Packaging for NDA: 065022
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
BACITRACIN ZINC AND POLYMYXIN B SULFATE | bacitracin zinc; polymyxin b sulfate | OINTMENT;OPHTHALMIC | 065022 | ANDA | Padagis US LLC | 0574-4021 | 0574-4021-35 | 1 TUBE in 1 CARTON (0574-4021-35) / 3.5 g in 1 TUBE |
BACITRACIN ZINC AND POLYMYXIN B SULFATE | bacitracin zinc; polymyxin b sulfate | OINTMENT;OPHTHALMIC | 065022 | ANDA | RPK Pharmaceuticals, Inc. | 53002-9270 | 53002-9270-1 | 3.5 g in 1 TUBE (53002-9270-1) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | OINTMENT;OPHTHALMIC | Strength | 500 UNITS/GM;10,000 UNITS/GM | ||||
Approval Date: | Feb 27, 2002 | TE: | AT | RLD: | No |
Complete Access Available with Subscription